 |
(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole |
|---|---|
| Trade Name | |
| Orphan Indication | Pulmonary tuberculosis |
| USA Market Approval | USA |
| USA Designation Date | 2007-07-12 00:00:00 |
| Sponsor | Otsuka Pharmaceutical Company, Ltd;2440 Research Blvd;Rockville, Maryland, 20850 |
